SOPHiA DDM™ for
Solid Tumors

Translating complex data into insights

pink dots icon

Clinical researchers are faced with the challenge of analyzing and interpreting increasingly complex genomic datasets. We help by generating insights from next-generation sequencing (NGS) data.

pink dots icon

Accurate variant detection

Our SOPHiA DDM™ for Solid Tumors solutions enable advanced, in-house analysis of complex variant classes. The algorithm-powered capabilities of the SOPHiA DDM™ Platform support accurate detection of single nucleotide variants (SNVs), insertions and deletions (Indels) and copy number variations (CNVs), as well as mutational biomarkers, such as:

A universal health data analytics platform for a decentralized approach to healthcare

Gene fusions

Found across solid tumor types, such as lung, colorectal, skin and brain cancers. Our technology covers key fusion biomarkers, including NTRK and RET, and supports novel fusion detection.

A universal health data analytics platform for a decentralized approach to healthcare

MET exon14 skipping

A rare oncogenic driver and therapeutic target for non-small cell lung carcinomas.

A universal health data analytics platform for a decentralized approach to healthcare

Gene amplification

Amplification has prognostic and diagnostic implications and is a mechanism of acquired drug resistance.

A universal health data analytics platform for a decentralized approach to healthcare

Microsatellite Instability (MSI)

A molecular fingerprint for defects in the mismatch repair pathway, associated with colorectal and other cancers.

A universal health data analytics platform for a decentralized approach to healthcare

Tumor Mutational Burden (TMB)

A prognostic biomarker that measures the quantity of mutations in tumor cells.

A universal health data analytics platform for a decentralized approach to healthcare

Genomic Integrity (GI)

Our deep learning-powered GI Index recognizes patterns of genomic instability associated with homologous recombination deficiency in high-grade serous ovarian cancer.

Streamlined variant assessment

Interpretation has been one of the most complex and time-consuming aspects of transforming genomic data into meaningful results. The SOPHiA DDM™ for Solid Tumors solutions are equipped with intuitive variant filters and automatic, artificial intelligence-enabled prioritization options that streamline and accelerate the interpretation workflow.

Illustrative representation of tertiary analysis workflow in SOPHiA DDM™.

Illustrative representation of the OncoPortal Plus functionality.

Advanced decision-making support

The OncoPortal Plus feature for SOPHiA DDM™ matches solid tumor molecular profiles with clinical associations and available clinical trials, leveraging expertly curated evidence powered by JAX-CKB™. After interpretation, the flexible reporting tools enables you to prepare push-button, comprehensive reports that are customizable to your needs.

pink dots icon

Discover our solutions

SOPHiA DDM HRD Solution

A universal health data analytics platform for a decentralized approach to healthcare

RNAtarget Technology by SOPHiA GENETICS

A universal health data analytics platform for a decentralized approach to healthcare

SOPHiA DDM™ for CGP

A universal health data analytics platform for a decentralized approach to healthcare

SOPHiA Solid Tumor Solutions

A universal health data analytics platform for a decentralized approach to healthcare

SOPHiA Homologous Recombination Solutions

A universal health data analytics platform for a decentralized approach to healthcare

CE-IVD Products

A universal health data analytics platform for a decentralized approach to healthcare
pink dots icon

Want to know more?
Get in touch with us.

Our client services team is on hand to help.